Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PIRAMID: Pirtobrutinib Plus R-CHOP vs. R-CHOP in Previously Untreated Richter Transformation
NCT07220187Phase 3Recruiting
- Sponsor
- SWOG Cancer Research Network
- Start
- Aug 2026
- Primary completion
- Oct 2035
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pirtobrutinib in Richter syndrome (RS), sponsored by SWOG Cancer Research Network. Started Aug 2026; status: recruiting.
02
Drugs
pirtobrutinib
03
Conditions
Richter syndrome (RS)
Beyond the preview
Go deeper on NCT07220187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07220187.